课题基金 / 基金详情

Solution of the molecular mechanism about proliferation / recurrence of the prostate cancer and the architecture of the comprehensive treatment strategy for he prostate cancer

Solution of the molecular mechanism about proliferation / recurrence of the prostate cancer and the architecture of the comprehensive treatment strategy for he prostate cancer
解决前列腺癌增殖/复发的分子机制及前列腺癌综合治疗策略架构
批准号:
23390379
负责人:
NAMIKI Mikio
金额:
$3.49万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011-11-18 至 2014-03-31

项目摘要

项目成果

NAMIKI Mikio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We performed cDNA microarray analysis with normal prostate tissue and the prostate cancer tissue, and identified SOD3 as the gene which the expression attenuated with prostate cancer tissue.We revealed that expression diminishment of SOD3 was associated with proliferation of prostate cancer, migration, and invasion. Also, we paid attention to extracellular matrix SPARC. Expression of SPARC attenuated with prostate cancer-derived stromal cells than normal stromal cells, and inhibited a proliferation and the migration of the cancer cells by inhibiting AKT phosphorylation. SPARC acted on cancer cells via integrin beta 1 as a receptor. Also, 2'-hydroxyflavanone which is the plant flavonoid showed antitumor effect for prostate cancer via apoptosis, and revealed that 2'-hydroxyflavanone inhibited androgen receptor activity, but did not inhibit androgen synthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SPARC Suppresses Proliferation and Migration of LNCaP Human prostate cancer cell
SPARC 抑制 LNCaP 人前列腺癌细胞的增殖和迁移
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Shin M, et al]
通讯作者: et al
Repression of cell proliferation and androgen receptor activity in prostate cancer cells by 2'-hydroxyflavanone
2-羟基黄烷酮抑制前列腺癌细胞的细胞增殖和雄激素受体活性
DOI: --
发表时间: 2013
期刊: Anticancer Research
影响因子: 2
作者: [M. Ofude, A. Mizokami, M. Kumaki, K. Izumi, H. Konaka, Y. Kadono, Y. Kitagawa, M. Shin, J. Zhang, E. T. Keller and M. Namiki]
通讯作者: E. T. Keller and M. Namiki
SOD3 Overexpression Inhibits Growth and Migration in PC-3 Human Prostate Cancer Cells
SOD3 过表达抑制 PC-3 人前列腺癌细胞的生长和迁移
DOI: --
发表时间: 2014
期刊:
影响因子: --
作者: [Jungim Kim, et al]
通讯作者: et al
Elucidation of mechanisms of the prostate cancer progress in consideration of AR Axis / microenvironment and the construction of the innovative treatment strategy
  • 批准号:
    26293350
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.4万
  • 财政年份:
    2014
  • 负责人:
    NAMIKI Mikio
  • 依托单位:
Exploration of gene impairments assosiated with non-coding DNA, which involves in an Alu sequences causing male infertility
  • 批准号:
    25670679
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2013
  • 负责人:
    NAMIKI Mikio
  • 依托单位:
The basic research for elucidation of molecular mechanism of the prostate cancer recurrence and the treatment strategy construction
  • 批准号:
    20390421
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.48万
  • 财政年份:
    2008
  • 负责人:
    NAMIKI Mikio
  • 依托单位:
Basic research of gene targeting and molecular targeting therapy for relapse of prostate cancer
  • 批准号:
    15390488
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $8.06万
  • 财政年份:
    2003
  • 负责人:
    NAMIKI Mikio
  • 依托单位:
国内基金
海外基金
过表达GABPA靶向激活SOD3减轻氧化应激保护小鼠免受强直性脊柱炎导致的损伤
  • 批准号:
    2026JJ82278
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    吴文欣
  • 依托单位:
IL-33/SOD3调控牙槽骨重塑并反向调控牙骨质代谢的机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    徐晖
  • 依托单位:
压应力环境下FoxO3/SOD3环路介导巨噬细胞极化失衡导致炎性牙根吸收的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    黄兰
  • 依托单位:
小分子化合物BNTA通过上调SOD3促进软骨细胞外基质合成对骨关节炎的治疗作用机制研究
  • 批准号:
    81972101
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    敖英芳
  • 依托单位: